Chengyan Zhou

Chengyan Zhou

Auto-generated profile, based on publicly available information

Chengyan Zhou

College of Pharmaceutical Science, Hebei University, Baoding 071002, China; State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Hebei University, Baoding 071002, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2019 in Food & Function
Verified
Journal Article
Closed access
PDF file
MLMengran Li
Mengran Li
CWChunxiao Wu
Chunxiao Wu
HGHongbin Guo
Hongbin Guo
CCCe Chu
Ce Chu
MHMingye Hu
Mingye Hu
CZChengyan Zhou
Chengyan Zhou
This study was conducted to investigate the beneficial effects and possible mechanism of action of mangiferin (MF) in alcohol hepatitis (AH) rats. Building on our previous study, the damage-associated molecular patterns (DAMPs), lipid metabolic disorder and mitochondrial dysfunction were investigated. MF effectively regulated the abnormal liver function, the levels of alcohol, FFAs and metal elements in serum. More importantly, MF improved the expression levels of mRNA and protein of PPAR-γ, OPA-1, Cav-1, EB1, NF-κB p65, NLRP3, Cas-1 and IL-1β, and decreased the positive protein expression rates of HSP90, HMGB1, SYK, CCL20, C-CAS-3, C-PARP and STARD1. Additionally, MF decreased the levels of fumarate, cAMP, xanthurenic acid and D-glucurone-6,3-lactone, and increased the levels of hippuric acid and phenylacetylglycine, and then adjusted the changes of phenylalanine metabolism, TCA cycle and ascorbate and aldarate metabolic pathways. The above results suggested that MF can effectively prevent AH by modulating specific AH-associated genes, potential biomarkers and metabolic pathways in AH rats, etc.

15 December 2022 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
CZChuanping Zhao
Chuanping Zhao
ZPZejiang Pu
Zejiang Pu
JGJian Gao
Jian Gao
CLChang Liu
Chang Liu
JXJianzhong Xing
Jianzhong Xing
CZChengyan Zhou
Chengyan Zhou

11 August 2024 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
WSWeichen Sun
Weichen Sun
XZXiaoting Zuo
Xiaoting Zuo
YZYu Zhang
Yu Zhang
CZChengyan Zhou
Chengyan Zhou
SGShuai Guo
Shuai Guo
JQJianglei Qin
Jianglei Qin

14 November 2019 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
HGHongbin Guo
Hongbin Guo
MCMengqiao Chen
Mengqiao Chen
MLMengran Li
Mengran Li
MHMingye Hu
Mingye Hu
BCBaohua Chen
Baohua Chen
CZChengyan Zhou
Chengyan Zhou
Mangiferin (MG) is an active component in natural medicines, and various studies have been reported on pharmacological effects, but the low solubility and bioavailability of MG limit its wide application. The aim of the present study was to investigate the pharmacokinetic profiles of mangiferin (MG) and mangiferin monosodium salt (MG-Na) in rat plasma by UPLC-MS/MS, which were then compared between the two groups. An appropriate high sensitivity and selectivity ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was applied to the comparison of plasma pharmacokinetics in MG and MG-Na using carbamazepine as internal standard (IS). These results showed that there were statistically significant differences in the pharmacokinetic parameters between MG and MG-Na after a single oral administration at 100 mg/kg. When compared with pharmacokinetic parameters of MG, the AUC(0-t), AUC(0–∞), Cmax,K10, and Ka of MG-Na were increased by 5.6-, 5.7-, 20.8-, 8-, and 83.6-fold, while the Tmax and CL/F were decreased by 4- and 5.7-fold (P<0.001), respectively. t1/2 value showed an increasing trend, but was statistically significant between the two groups. Moreover, the AUC value in the MG-Na group was significantly increased and the relative bioavailability was calculated to be 570% when compared with that of the MG group. These results suggested that the salification reaction of MG can effectively enhance gastrointestinal absorption and relative bioavailability by improving solubility and membrane permeability.

4 July 2022 in Food & Function
Verified
Journal Article
Closed access
PDF file
CZChuanping Zhao
Chuanping Zhao
JTJiamei Tang
Jiamei Tang
XLXiaoya Li
Xiaoya Li
ZYZihan Yan
Zihan Yan
LZLiangliang Zhao
Liangliang Zhao
CZChengyan Zhou
Chengyan Zhou
Despite considerable advances in prevention, diagnosis, and therapy, nephrotic syndrome (NS) remains a significant cause of high morbidity and mortality globally. As a result, there is an urgent need to identify novel effective preventative and therapeutic agents for NS. NS is implicated in glomerular permselectivity injury, which can be attributed to oxidative distress, inflammation, lipid nephrotoxicity, podocyte apoptosis, autophagy dysfunction, and slit diaphragm (SLD) dysfunction. In addition to its well-documented antioxidant potency, procyanidin B2 (PB2) may exhibit pleiotropic effects by targeting various canonical signaling events, such as NF-κB, PPARs, PI3K/Akt, mTOR, and the caspase family. As a result, PB2 may be a promising therapeutic target against NS. To test this hypothesis, we established an Adriamycin (ADR)-induced NS mouse model to evaluate the pleiotropic renoprotective effects of PB2 on NS. Here, we demonstrated that PB2 improves podocyte injury via inhibition of NOX4/ROS and Hsp90/NF-κB to exhibit antioxidant and anti-inflammatory potency, respectively. We also show that PB2 indirectly activates the PI3K/Akt axis by regulating SLD protein levels, resulting in normalized podocyte apoptosis and autophagy function. Further, loss of albumin (ALB) induces lipid nephrotoxicity, which we found to be alleviated by PB2 via activation of PPARα/β-mediated lipid homeostasis and the cholesterol efflux axis. Interestingly, our results also suggested that PB2 reduces electrolyte abnormalities and edema. In addition, PB2 may contribute protective effects against trace element dys-homeostasis, which, through alleviating serum ALB loss, leads to a protective effect on glomerular permselectivity injury. Taken together, our results reveal that the identified mechanisms of PB2 on NS are multifactorial and involve inhibition of oxidative distress and inflammatory responses, as well as improvements in podocyte apoptosis and autophagy dysfunction, amelioration of lipid nephrotoxicity, and modulation of electrolyte abnormalities and edema. Thus, we provide a theoretical basis for the clinical application of PB2 against NS.

24 January 2024 in Inorganic Chemistry
Verified
Journal Article
Closed access
XXXiaofeng Xie
Xiaofeng Xie
JZJiejing Zhang
Jiejing Zhang
XSXueqing Song
Xueqing Song
WLWan Li
Wan Li
FCFei Cao
Fei Cao
LLLongfei Li
Longfei Li